You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Version: 1.0 jan 2024
Type of Content: Guidelines & Advice, Recommendation Report
Document Status: Current
Authors:
MDS Working Group, MPN Working Group

Intended Guideline Users

Health care providers and administrators

Research Question(s)

What are the required and recommended diagnostic and prognostic tests for patients with MDS that are needed for clinical decision-making?

What are the required and recommended diagnostic and prognostic tests for patients with MPN that are needed for clinical decision-making?

What are the required and recommended diagnostic and prognostic tests for patients with MDS/MPN that are needed for clinical decision-making?

pdf download Full Report (PDF) (691.92 Ko)